Geron Corp
NASDAQ:GERN
Geron Corp
NASDAQ:GERN
Price:
3.87 USD
3.75%
Market Closed
Updated:
May 8, 2024
Geron Corp
Cash from Operating Activities
|
Geron Corp
Cash from Operating Activities Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Geron Corp
NASDAQ:GERN
|
Cash from Operating Activities
-$183.6m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
-20%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Cash from Operating Activities
$22.8B
|
CAGR 3-Years
9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
14%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash from Operating Activities
$8B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
1%
|
CAGR 10-Years
7%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Operating Activities
$8.1B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
2%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash from Operating Activities
$3.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash from Operating Activities
$4.7B
|
CAGR 3-Years
22%
|
CAGR 5-Years
14%
|
CAGR 10-Years
24%
|
See Also
What is Geron Corp's Cash from Operating Activities?
Cash from Operating Activities
-183.6m
USD
-183.6m
USD
Based on the financial report for Mar 31, 2024, Geron Corp's Cash from Operating Activities amounts to -183.6m USD.
What is Geron Corp's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-20%
-20%
Over the last year, the Cash from Operating Activities growth was -31%. The average annual Cash from Operating Activities growth rates for Geron Corp have been -36% over the past three years , -47% over the past five years , and -20% over the past ten years .
You don't have any saved screeners yet
